Table 2.
Variables | AR (n = 22) | Control (n = 29) | P-values |
Age, years, median (IQR) | 30 (24–38) | 35 (27–47) | 0.105 |
Sex, male / female (n) | 19 / 3 | 20 / 9 | 0.192 |
Donor type, deceased / living (n) | 1 / 21 | 8 / 21 | 0.06 |
Median time of follow-up, months, median (IQR) | 8 (3–25) | 25 (8–60) | 0.05 |
Diabetes, negative / positive | 22 / 0 | 28 / 1 | - |
Hypertension, negative / positive (n) | 21 / 1 | 23 / 6 | 0.550 |
Creatinine, mg/dL, median (IQR) | 1.2 (1.0–1.5) | 1.1 (1.4–0.9) | 0.307 |
White blood cells, mm3, median (IQR) | 9700 (6857–12800) | 7500 (6345–10250) | 0.223 |
Uric acid level, mg/dL, median (IQR) | 6.9 (5.4–8.1) | 5.8 (4.8–6.8) | 0.043 |
ESR, mm/h, median (IQR) | 30 (24–45) | 22 (11–49) | 0.531 |
NLR, median (IQR) | 4.06 (3.11–7.03) | 1.24 (1.08–1.57) | <0.001 |
IQR: Interquartile range, ESR: erythrocyte sedimentation rate, NLR: Neutrophil-to-lymphocyte ratio.